ozempic semaglutide patent expiration date expiry in India opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent India's generic semaglutide surge |

Half the planet is projected to be overweight or obese by 2035, and excess weight is linked to type 2 diabetes, heart disease and some cancers

(1-3) Its active ingredient, semaglutide, is also used in Wegovy, which the FDA has approved for treating obesity

[(accessed on 15 November 2025)];2017 Available online: 69.Novo Nordisk Inc Wegovy (Semaglutide) Injection for Subcutaneous Use, U.S

As competition intensifies and new formulations move through regulatory and clinical milestones, the GLP-1 market is poised to remain a major driver of growth and innovation across the broader pharmaceutical industry

Prevalence of hereditary Haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study

A 2019 systematic review in Frontiers in Pharmacology found berberine safe when co-administered with metformin and sulfonylureas, suggesting tolerability with other metabolic agents